How is targeted therapy for lung cancer?

Targeted therapy is a treatment approach used for certain types of lung cancer and generally yields favorable results in treating lung cancer.

Targeted therapy primarily involves the use of specific medications, such as gefitinib tablets, erlotinib hydrochloride tablets, and atezolizumab injection, which can precisely identify and control the growth, division, and spread of cancer cells in the body. This helps slow disease progression and prolong patients' survival. Additionally, targeted therapy avoids the trauma and discomfort associated with invasive procedures such as thoracotomy or laparotomy. It can be used as a standalone treatment or combined with other modalities such as surgery or radiotherapy to improve patients' quality of life. However, before receiving these treatments, patients need to undergo a series of medical tests, including biopsy and genetic testing, to determine whether their tumors express the specific molecular targets for the drugs.

Lung cancer is a type of tumor disease that may cause symptoms such as coughing, hemoptysis (coughing up blood), chest tightness, and difficulty breathing. Individuals experiencing these symptoms are advised to seek medical evaluation at a hospital and receive appropriate treatment under a doctor's guidance.